ZA201401636B - Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator - Google Patents

Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator

Info

Publication number
ZA201401636B
ZA201401636B ZA2014/01636A ZA201401636A ZA201401636B ZA 201401636 B ZA201401636 B ZA 201401636B ZA 2014/01636 A ZA2014/01636 A ZA 2014/01636A ZA 201401636 A ZA201401636 A ZA 201401636A ZA 201401636 B ZA201401636 B ZA 201401636B
Authority
ZA
South Africa
Prior art keywords
solvates
acid addition
addition salts
oxalic acid
estrogen receptor
Prior art date
Application number
ZA2014/01636A
Other languages
English (en)
Inventor
Srinivas Laxminarayan Pathi
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Chandrasekaran Ramasubbu
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ZA201401636B publication Critical patent/ZA201401636B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2014/01636A 2013-03-05 2014-03-05 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator ZA201401636B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN665MU2013 IN2013MU00665A (sv) 2013-03-05 2014-03-05

Publications (1)

Publication Number Publication Date
ZA201401636B true ZA201401636B (en) 2014-11-26

Family

ID=50382470

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/01636A ZA201401636B (en) 2013-03-05 2014-03-05 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator

Country Status (3)

Country Link
IN (1) IN2013MU00665A (sv)
WO (1) WO2014135834A1 (sv)
ZA (1) ZA201401636B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016279330B2 (en) 2015-06-16 2020-05-14 Jiangsu Hengrui Medicine Co., Ltd. Piperidine derivative and preparation method and pharmaceutical use thereof
MX2018007844A (es) 2015-12-22 2019-01-21 Jiangsu Hengrui Medicine Co Derivado de benzopiperidina, metodo de preparacion del mismo y su uso medico del mismo.
KR20220125272A (ko) 2020-01-10 2022-09-14 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 트리사이클릭 테트라하이드로이소퀴놀린 유도체, 이를 제조하기 위한 방법 및 의료분야에서 이의 용도
TW202317582A (zh) 2021-07-09 2023-05-01 大陸商江蘇恒瑞醫藥股份有限公司 三環四氫異喹啉類衍生物的鹽型

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4358593A (en) 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CO4410190A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli 3-[4-(2-AMINOETOXI)-BENZOIL]-2-ARIL-6-HIDROXIBENZO [b] TIOFENO CRISTALINO
US5629425A (en) * 1994-09-19 1997-05-13 Eli Lilly And Company Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
AU7165398A (en) 1997-04-30 1998-11-24 Eli Lilly And Company A regioselective alkylation process for preparing substituted benzo{b}thiophenes
EP1832583A1 (en) 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Novel raloxifene sulphuric acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
JP2009541385A (ja) * 2006-06-27 2009-11-26 サンド・アクチエンゲゼルシヤフト 塩の製造のための新規な方法
WO2008047105A1 (en) * 2006-10-17 2008-04-24 Cipla Limited Crystalline form of benzothiophene compound and process for preparation thereof
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy

Also Published As

Publication number Publication date
IN2013MU00665A (sv) 2015-07-03
WO2014135834A1 (en) 2014-09-12
WO2014135834A8 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
IL281240A (en) Androgen receptor modulator and uses
HUS2100047I1 (hu) Egy androgén receptor modulátor kristályos formái
HK1214532A1 (zh) 雌激素受體調節劑及其用途
HK1222101A1 (zh) 流出裝置
GB201315630D0 (en) Shuttering system
PL3068685T3 (pl) Przewłoka prowadząca elementu kotwicznego
GB2529102B (en) Improved printing of security devices
PL2895287T3 (pl) Kombinacja materiałów dla urządzeń do dozowania rtęci oraz urządzenia zawierające wspomnianą kombinację materiałów
IL240019A0 (en) Estrogen receptor inhibitors
ZA201401636B (en) Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
IL244412A0 (en) Liver X receptor modulators (lrx)
IL244418B (en) Liver X receptor modulators (lrx)
IL249160A0 (en) Crystal forms of an estrogen receptor modulator
HK1223152A1 (zh) 用於固相和液相之間的反應的改進的設備和方法
TH1401007292A (th) รูปแบบผลึกของแอนโดรเจนรีเซปเตอร์มอดูเลเตอร์